# Neumora Therapeutics, Inc.: Form 8-K, filed May 16, 2025

- Company: [Neumora Therapeutics, Inc.](/companies/nmra.md) (CIK 1885522)
- Form: 8-K
- Filed: 2025-05-16
- Accepted by EDGAR: May 16, 2025, 16:26 ET
- Period: 2025-05-14
- Accession: 0001193125-25-121714
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1885522/000119312525121714/d933150d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1885522/000119312525121714/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1885522/000119312525121714/d933150d8k.htm

Filed May 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-121714. Last ingested by Listed: Oct 30, 2026, 16:11 ET. No prices; not investment advice.
